Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Curti

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Biochemistry|July 4, 1995
Involvement of serine 96 in the catalytic mechanism of ferredoxin-NADP+ reductase: structure--function relationship as studied by site-directed mutagenesis and X-ray crystallographyA Aliverti, C M Bruns, V E Pandini, et al.
Structure (London, England : 1993)|February 24, 2001
Cross-talk and ammonia channeling between active centers in the unexpected domain arrangement of glutamate synthaseC Binda, R T Bossi, S Wakatsuki, et al.
Biochemistry|March 4, 1998
The recombinant alpha subunit of glutamate synthase: spectroscopic and catalytic propertiesM A Vanoni, F Fischer, S Ravasio, et al.
International Journal of Oncology|May 11, 2011
Phase i/ii trial of 5-Fluorouracil, leucovorin, Zidovudine and dipyridamole for patients with metastatic colorectal-cancer, renal-cell carcinoma and malignant-melanomaW Sharfman, W Urba, J Smith, et al.
Journal of the National Cancer Institute|June 3, 1992
Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changesJ B Ochoa, B Curti, A B Peitzman, et al.
Minerva Medica|February 25, 1983
[Computerized methods in the diagnosis and prognosis of surgically treated bilio-pancreatic diseases]T Festa, A Foco, U Serenthà, et al.
Developments in Biologicals|December 18, 2004
Manipulating the host response to autologous tumour vaccinesJ Ma, C H Poehlein, S M Jensen, et al.
Journal for Immunotherapy of Cancer|March 29, 2019
Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM<sup>SM</sup> registryM Fishman, J P Dutcher, J I Clark, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Biochemistry|July 4, 1995
Involvement of serine 96 in the catalytic mechanism of ferredoxin-NADP+ reductase: structure--function relationship as studied by site-directed mutagenesis and X-ray crystallographyA Aliverti, C M Bruns, V E Pandini, et al.
Structure (London, England : 1993)|February 24, 2001
Cross-talk and ammonia channeling between active centers in the unexpected domain arrangement of glutamate synthaseC Binda, R T Bossi, S Wakatsuki, et al.
Biochemistry|March 4, 1998
The recombinant alpha subunit of glutamate synthase: spectroscopic and catalytic propertiesM A Vanoni, F Fischer, S Ravasio, et al.
International Journal of Oncology|May 11, 2011
Phase i/ii trial of 5-Fluorouracil, leucovorin, Zidovudine and dipyridamole for patients with metastatic colorectal-cancer, renal-cell carcinoma and malignant-melanomaW Sharfman, W Urba, J Smith, et al.
Journal of the National Cancer Institute|June 3, 1992
Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changesJ B Ochoa, B Curti, A B Peitzman, et al.
Minerva Medica|February 25, 1983
[Computerized methods in the diagnosis and prognosis of surgically treated bilio-pancreatic diseases]T Festa, A Foco, U Serenthà, et al.
Developments in Biologicals|December 18, 2004
Manipulating the host response to autologous tumour vaccinesJ Ma, C H Poehlein, S M Jensen, et al.
Journal for Immunotherapy of Cancer|March 29, 2019
Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM<sup>SM</sup> registryM Fishman, J P Dutcher, J I Clark, et al.
Pageof 5